China Pharma Holdings, Inc. Reports Second Quarter 2018 Financial Results
HAIKOU CITY, China, Aug. 15, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended June 30, 2018.
- HAIKOU CITY, China, Aug. 15, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended June 30, 2018.
- Revenue increased8.8% to $3.2million in the second quarter 2018 from $3.0million in the same period of 2017;
Gross profit was$0.6 million for each of the three months ended June 30, 2018 and 2017, respectively. - Gross margin was 18.3% in the second quarter of 2018, compared to 22.2% in the same period of 2017;
Loss from operations was $0.9million in the second quarter of 2018 compared to $2.1 million in the same period of 2017, a decrease of $1.2 million;
Net loss was $1.0 million in the second quarter of 2018 compared to $2.3 million in the same period of 2017. - on August 15, 2018, to discuss the financial results of the second quarter 2018.